Home Is pharmacologic research on pregnant women with psychoses ethically permissible?
Article
Licensed
Unlicensed Requires Authentication

Is pharmacologic research on pregnant women with psychoses ethically permissible?

  • Laurence B. McCullough EMAIL logo , John H. Coverdale and Frank A. Chervenak
Published/Copyright: November 11, 2014

Abstract

There is a consistent view in the literature that research on pregnant woman with psychoses is ethically questionable or impermissible. This paper provides a critical appraisal of these views by asking whether pharmacologic research on pregnant women with psychosis for maternal, fetal, and newborn benefit is ethically permissible. We examine separately the documented clinical benefits and risks to the pregnant patient, the fetal patient, and the neonatal and pediatric patient. The outcomes reported in the pertinent literature do not support the conclusion that pharmacologic management of psychosis during pregnancy results in documented, unacceptable risk to the pregnant, fetal, or neonatal patient and is therefore ethically ruled out. Claims that research on the pharmacologic management of psychosis during pregnancy is ethically impermissible because of unacceptable risk of harm to pregnant, fetal, neonatal, or pediatric patients cannot therefore be supported. Having shown that such research is permissible, we then ask what ethical considerations should guide study design. We show that Phase I studies are appropriate and can meet the requirements of the Common Rule, which are more specific than international guidance. As a matter of professionally responsible obstetric practice, pregnant women with psychoses should be included, and not be neglected, in research for both maternal and fetal benefit.


Corresponding author: Laurence B. McCullough, Center for Medical Ethics and Health Policy, Baylor College of Medicine, One Baylor Plaza, MS 420, Houston, TX 77030, USA, Tel.: +713 798 3505, Fax: 713 798 5678, E-mail:

References

[1] ACOG Committee on Practice Bulletins – Obstetrics. ACOG Practice Bulletin No. 92: use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 2008;111:1001–20.10.1097/AOG.0b013e31816fd910Search in Google Scholar PubMed

[2] McCullough LB, Coverdale J, Chervenak F. Ethical challenges of decision making with pregnant patients who have schizophrenia. Am J Obstet Gynecol. 2002;187:696–700.10.1067/mob.2002.125767Search in Google Scholar PubMed

[3] Hartz SM, Pato CN, Medeiros H, Cavazos-Rehg P, Sobell JL, Knowles JA, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014;71:248–54.10.1001/jamapsychiatry.2013.3726Search in Google Scholar PubMed PubMed Central

[4] Coverdale J, Turbott SH. Sexual and physical abuse of chronically ill psychiatric outpatients compared to men with a matched sample of medical outpatients. J Nerv Ment Dis. 2000;188:440–5.10.1097/00005053-200007000-00008Search in Google Scholar PubMed

[5] Oram S, Trevillion K, Feder G, Howard LM. Prevalence of experiences of domestic violence among psychiatric patients:a systematic review. Br J Psychiatry. 2013;202:94–9.10.1192/bjp.bp.112.109934Search in Google Scholar PubMed

[6] Teplin LA, McClelland GM, Abram KM, Weiner DA. Crime victimization in adults with severe mental illness: comparison with the National Crime Victimization Survey. Arch Gen Psychiatry. 2005;62:911–21.10.1001/archpsyc.62.8.911Search in Google Scholar PubMed PubMed Central

[7] Webb RT, Howard L, Abel KM. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. Cochrane Database Syst Rev. 2004;CD004411.10.1002/14651858.CD004411.pub2Search in Google Scholar PubMed

[8] Abel KM. Fetal antipsychotic exposure in a changing landscape: seeing the future. Br J Psychiatry. 2013;202:321–3.10.1192/bjp.bp.112.117556Search in Google Scholar PubMed

[9] Spinelli, M. Antidepressant treatment during pregnancy. Am J Psychiatry. 2012:169:121–4.10.1176/appi.ajp.2011.11111622Search in Google Scholar PubMed

[10] Howard L, Webb R, Abel K. Safety of antipsychotic drugs for pregnant and breastfeeding women with non-affective psychosis. Br Med J. 2004;329:933–4.10.1136/bmj.329.7472.933Search in Google Scholar PubMed PubMed Central

[11] Yaeger D, Smith HG, Altshuler LL. Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum. Am J Psychiatry. 2006;163:2064–70.10.1176/ajp.2006.163.12.2064Search in Google Scholar PubMed

[12] Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2010;36:518–44.10.1093/schbul/sbn107Search in Google Scholar PubMed PubMed Central

[13] Paton C. Prescribing in pregnancy. Br J Psychiatry. 2008;192:321–2.10.1192/bjp.bp.108.049585Search in Google Scholar PubMed

[14] Chervenak FA, McCullough LB. An ethically justified framework for clinical investigation to benefit pregnant and fetal patients. Am J Bioeth. 2011;11:39–49.10.1080/15265161.2011.562595Search in Google Scholar PubMed

[15] Coverdale J, McCullough LB, Chervenak FA. The ethics of randomized placebo-controlled trials of antidepressants with pregnant women: a systematic review. Obstet Gynecol. 2008;112:1361–8.10.1097/AOG.0b013e31818c2a27Search in Google Scholar PubMed

[16] McCullough LB, Coverdale J, Chervenak FA. A comprehensive ethical framework for responsibly designing and conducting pharmacologic research that involves pregnant women. Am J Obstet Gynecol. 2005;193:901–7.10.1016/j.ajog.2005.06.020Search in Google Scholar PubMed

[17] McCullough LB, Chervenak FA, Coverdale J. An ethical framework for conducting research on pregnant, opioid-dependent women. Addiction. 2013;108:248–9.10.1111/j.1360-0443.2012.03865.xSearch in Google Scholar PubMed

[18] Council for the International Organization of Medical Societies (CIOMS), in conjunction with the World Medical Association (WMA). International Guidelines for Biomedical Research Involving Human Subjects. Geneva: CIOMS, 2002. http://www.cioms.ch/publications/layout_guide2002.pdf, accessed on July 2, 2014.Search in Google Scholar

[19] Beauchamp TL, Childress JF. Principles of biomedical ethics. 7th ed. New York: Oxford University Press; 2013.Search in Google Scholar

[20] McCullough LB, Chervenak FA. Ethics in obstetrics and gynecology. New York: Oxford University Press; 1994.Search in Google Scholar

[21] Miller LJ. Psychotic denial of pregnancy: phenomenology and clinical management. Hosp Comm Psychiatry. 1990;41:1233–7.10.1176/ps.41.11.1233Search in Google Scholar PubMed

[22] Babbitt KE, Bailey KJ, Coverdale J, Chervenak FA, McCullough LB. Professionally responsible intrapartum management of patients with major mental disorders. Am J Obstet Gynecol. 2014;210:27–31.10.1016/j.ajog.2013.06.024Search in Google Scholar PubMed

[23] Coverdale J, Turbott SH, Roberts H. Family planning needs and STD risk behaviors of female psychiatric outpatients. Br J Psychiatry. 1997;171:69–72.10.1192/bjp.171.1.69Search in Google Scholar PubMed

[24] Boden R, Lundgren M, Brandt L, Reutfors J, Kieler H. Antipsychotics during pregnancy; relation to fetal and maternal metabolic effects. Arch Gen Psychiatry. 2012;69:715–721.10.1001/archgenpsychiatry.2011.1870Search in Google Scholar PubMed

[25] Reis M, Kallen B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol. 2008;28:279–88.10.1097/JCP.0b013e318172b8d5Search in Google Scholar PubMed

[26] Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich L-A. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry. 2005;162:79–91.10.1176/appi.ajp.162.1.79Search in Google Scholar PubMed

[27] Schneid-Kofman N, Sheiner E, Levy A. Psychiatric illness and adverse pregnancy outcome. Int J Gynaecol Obstet. 2008;101:53–6.10.1016/j.ijgo.2007.10.007Search in Google Scholar PubMed

[28] Spielvogel A, Wile J. Treatment and outcomes of psychotic patients during pregnancy and childbirth. Birth. 1992;19:131–7.10.1111/j.1523-536X.1992.tb00670.xSearch in Google Scholar PubMed

[29] Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB. Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch Gen Psychiatry. 2001;58:674–679.10.1001/archpsyc.58.7.674Search in Google Scholar PubMed

[30] Newham JJ, Thomas SH, MacRitchie K, McElhatton PR, McAllister-Williams RH. Birth weights of infants after maternal exposure to typical and atypical antipsychotics; prospective comparison study. B J Psychiatry. 2008;192:333–7.10.1192/bjp.bp.107.041541Search in Google Scholar PubMed

[31] Webb R, Abel K, Pickles A, Appleby L. Mortality in offspring of parents with psychotic disorders: a critical review and meta-analysis. Am J Psychiatry. 2005;162:1045–6.10.1176/appi.ajp.162.6.1045Search in Google Scholar PubMed

[32] McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, et al. Pregnancy outcome of women using atypical antipsychotic drugs:a prospective comparative study. J Clin Psychiatry. 2005;66:444–9.10.4088/JCP.v66n0406Search in Google Scholar PubMed

[33] Nilsson E, Lichtenstein P, Cnattingius S, Murray RM, Hultman CM. Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophrenia. Research. 2002;58:221–9.10.1016/S0920-9964(01)00370-XSearch in Google Scholar

[34] Lin H-C, Chen I-J, Chen Y-H, Lee H-S, Wu F-J. Maternal schizophrenia and pregnancy outcome:does the use of antipsychotics make a difference? Schizophrenia Res. 2010;116:55–60.10.1016/j.schres.2009.10.011Search in Google Scholar PubMed

[35] Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry. 1996;153:592–606.10.1176/ajp.153.5.592Search in Google Scholar PubMed

[36] Diav-Citrin O, Shechtman S, Ornoy S, Amon J, Schaefer C, Garbis H, et al. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry. 2005;66:317–22.10.4088/JCP.v66n0307Search in Google Scholar

[37] Habermann F, Fritzsche J, Fuhlbruck F, Wacker E, Allignol A, Weber-Schoendorfer C, et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol. 2013;33:453–62.10.1097/JCP.0b013e318295fe12Search in Google Scholar PubMed

[38] Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport J. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012;69:787–94.10.1001/archgenpsychiatry.2012.160Search in Google Scholar PubMed PubMed Central

[39] World Medical Association. Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. 2013. http://www.wma.net/en/30publications/10policies/b3/, accessed on July 2, 2014.Search in Google Scholar

[40] Brody BA. The ethics of biomedical research: an international perspective. New York: Oxford University Press; 1998.10.1093/oso/9780195090079.001.0001Search in Google Scholar

The authors stated that there are no conflicts of interest regarding the publication of this article.

Received: 2014-7-10
Accepted: 2014-9-15
Published Online: 2014-11-11
Published in Print: 2015-7-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Erich Saling – The Father of Prenatal and Perinatal Medicine—Dedication to his 90th birthday
  4. Original articles - Obstetrics
  5. A transcervical amniotic fluid collector: a new medical device for the assessment of amniotic fluid in patients with ruptured membranes
  6. Advanced cervical dilatation and spontaneous preterm labor: a comparison between twin and singleton gestations
  7. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor
  8. Does recent sexual intercourse during pregnancy affect the results of the fetal fibronectin rapid test? A comparative prospective study
  9. Usefulness of maternal serum C-reactive protein with vaginal Ureaplasma urealyticum as a marker for prediction of imminent preterm delivery and chorioamnionitis in patients with preterm labor or preterm premature rupture of membranes
  10. Effect of blood on ROM diagnosis accuracy of PAMG-1 and IGFBP-1 detecting rapid tests
  11. Single versus combination tocolytic regimen in the prevention of preterm births in women: a prospective cohort study
  12. Recommendations of activity restriction in high-risk pregnancy scenarios: a Danish national survey
  13. Is pharmacologic research on pregnant women with psychoses ethically permissible?
  14. Women’s knowledge and attitude towards pregnancy in a high-income developing country
  15. Impact of maternal body mass index on the cesarean delivery rate in Germany from 1990 to 2012
  16. Justified skepticism about Apgar scoring in out-of-hospital birth settings
  17. The effect of the use of oxytocin on blood loss during different postpartum periods
  18. Original articles - Fetus
  19. The T/QRS ratio values in pregnancies complicated by threatened preterm labour treated with intravenous infusions of fenoterol
  20. Cardiotocography patterns and risk of intrapartum fetal acidemia
  21. Combined spinal epidural analgesia for labor using sufentanil epidurally versus intrathecally: a retrospective study on the influence on fetal heart trace
  22. Original articles - Newborn
  23. Predicting fetal growth deviation in parous women: combining the birth weight of the previous pregnancy and third trimester ultrasound scan
  24. Letter to the Editor
  25. A cerclage is not a modified total cervical occlusion!
  26. Letter Reply
  27. Reply to: a cerclage is not a modified Total Cervical Occlusion!
  28. Congress Calendar
  29. Congress Calendar
Downloaded on 25.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2014-0229/html
Scroll to top button